Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-17-033971

President and CEO sold 7,500 shares at an average $9.86 ($73,925)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Leuthner Brian A President and CEO 2017-12-01 Sale −2,500 $9.92 $24,800 95,236 D
Leuthner Brian A President and CEO 2017-12-04 Sale −2,500 $9.97 $24,925 92,736 D
Leuthner Brian A President and CEO 2017-12-05 Sale −2,500 $9.68 $24,200 90,236 D
Open-market sales · 7,500 sh · avg $9.86 · $73,925
Loading xslF345X03/form4.xml…